Company Profiles

driven by the PitchBook Platform

Ariadne Diagnostics

Description

Provider of molecular diagnostic services. The company offers companion diagnostic services for metastatic colorectal cancer and neuromuscular diseases.

2011

Founded

PRIVATE

Status

1-10

Employees

Seed

Latest Deal Type

$100k

Latest Deal Amount

$100k

Total Amount Raised

Description

Provider of molecular diagnostic services. The company offers companion diagnostic services for metastatic colorectal cancer and neuromuscular diseases.

Website:

www.ariadne-dx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

9430 Key West Avenue Suite 115 Rockville, MD 20850United States +1 (240) 345-1071 x104
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ariadne Diagnostics's full profile, request a free trial.

Ariadne Diagnostics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ariadne Diagnostics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
TEDCOVenture CapitalMinority000 0000000 0000
TEDCO Venture Capital

Ariadne Diagnostics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Ilya Mazo Ph.DCo-Founder & Acting Chief Executive Officer
Elena Schwartz Ph.DCo-Founder & Chief Scientific Officer
Michael Lebowitz Ph.DCo-Founder & Vice President, Research & Development
Nikolai Daraselia Ph.DFounder
Ilya Mazo Ph.D Co-Founder & Acting Chief Executive Officer
Elena Schwartz Ph.D Co-Founder & Chief Scientific Officer
Michael Lebowitz Ph.D Co-Founder & Vice President, Research & Development
Nikolai Daraselia Ph.D Founder
Request full access to PitchBook